Molecular genetic studies conducted during the last several years have thrown some light on the basic molecular defects in primary congenital glaucoma (PCG) and the rationale behind the clinical ...

Background Normal tension glaucoma (NTG ... Only the right eye was used for statistical analysis. Results In 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye ...

While there is no cure for this group of eye diseases, there are treatments that can halt progression and prevent vision loss ...

Exophthalmos and corneal edema in a young ferret,” in which we diagnosed an 8-week-old ferret with glaucoma in its right eye. Subsequently ... Because pre-weaned animals spend most of their ...

The fellow will divide time among faculty members and gain hands-on experience in the pre-operative evaluation, surgical management and post-operative care of the full spectrum of glaucoma. The fellow ...

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company ...

Iridex (IRIX) announced the publication of a peer-reviewed study in Ophthalmology Therapy. This study highlights the sustained safety and ...

Glaucoma, a group of eye disorders damaging the optic nerve, is a leading cause of vision loss. In most cases, it results ...

More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to vision loss. It's the second-leading cause of blindness worldwide and ...